Parkinson's Disease Clinical Trial
Official title:
Power Training to Reduce Falls in Parkinson's Disease
Parkinson's disease (PD) is a chronic neurodegenerative disorder that is characterized by a multitude of symptoms. Impairments in balance, muscle deficits and increased risk of falls are commonly experienced in PD.The purpose of this study is to investigate the effects of two different resistance training programs on improving balance and muscular strength to thereby reduce the risk of falls in those with PD. This study will randomize individuals to one of two groups, a power training group, or a strength training group. Both interventional groups will participate in 12 weeks of resistance training, two times per week for an hour each exercise session.
Parkinson's disease (PD) is a neurodegenerative disorder that results in multiple hallmark
symptoms, such as balance impairments, postural instability and muscular deficits. These
symptoms, in combination with a deficient sensory-perceptual integration system, put
individuals with PD at a higher risk of falls and fractures, compared to healthy older
adults. With the expected rise in PD diagnosis, this will place an unprecedented burden on
the Canadian healthcare system due to increased hospitalizations, surgeries, placement into
long term care facilities, and rehabilitation. Improving symptom severity and delaying
disease progression through rehabilitation strategies that improve balance and muscular
deficits, can decrease falling risk in individuals with PD, potentially alleviating the
projected burden on the healthcare system. For these reasons it is imperative to have the
ability to directly measure the degree to which individuals with PD are at risk of
experiencing falls through objective techniques.
Purpose: Therefore the purpose of this study is to examine the effects of two different forms
of resistance training (RT) to improve the muscular deficits experienced, as well to improve
the balance impairments experienced as it has been suggested that RT is able to do this not
only in healthy older adults but in those with PD as well. The two RT programs that will be
investigated are a conventional strength training (ST) program and a high velocity strength
training, known as power training (PT) program.
Objective/Aim: The objective of this study is to identify if ST or PT is a more effective
rehabilitation program to improving muscle strength and power, balance measures and reducing
the risk of falls. Due to the nature of the PT intervention it is hypothesized that these
individuals will experience the greatest improvements in outcome measures.
Methods/Design: This study will be a double blind randomized controlled trial. Participants
will be blinded to group allocation except for the control group, however those in the
interventional group will only be informed that they are participating in a RT program. The
primary investigator will only collect measures that are considered to be objective at follow
up time points. Pre-intervention measures will all be collected prior to randomization into
group allocations. The assessor of disease severity will also be blinded to group allocation.
Participants will be randomized to one of three groups: i) a control group (to account for
normal disease progression for the duration of the intervention); ii) ST group and iii) PT
group.
The intervention will be a total of 12 weeks long, where participants will come in two days
per week for an hour long session each day, for a total of 24 session.
Participants randomized to the ST group will complete three sets of 8-10 repetitions at 70%
of their one repetition maximum (1-RM), as determined during their pre-test. Those randomized
to the PT group will complete three sets of 12-15 repetitions at 40% of their 1-RM, as
determined during their pre-test. Both programs involve individualized exercise prescriptions
based on the results of their predicted 1-RM. This program will be designed by a Canadian
Society for Exercise Physiology Certified Exercise Physiologist, who has the knowledge and
ability to safely test and prescribe exercise to individuals with chronic conditions. Both
programs will be progressive in nature, in that as each individual is able to complete the
last set, for two consecutive training sessions at the higher end of the range of repetitions
(i.e. for the ST group 10 or more repetitions), the next session their weight will be
increased by 5%. Upon completion participants will complete all outcome measures again. These
measures will be completed during a wash out period at 3 months and 6 months post
intervention to investigate the potential long term effects of these rehabilitation programs,
and if either is more advantageous in the long term.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Terminated |
NCT02894567 -
Evaluation of Directional Recording and Stimulation Using spiderSTN
|
N/A |